As of Jun 02
| 0.00 / 0.00%|
The 3 analysts offering 12-month price forecasts for Tonix Pharmaceuticals Holding Corp have a median target of 40.63, with a high estimate of 40.63 and a low estimate of 18.00. The median estimate represents a +2,060.90% increase from the last price of 1.88.
The current consensus among 2 polled investment analysts is to Buy stock in Tonix Pharmaceuticals Holding Corp. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.